Buy Celyad Stock | CYAD Stock Price & Latest News | Public
CYAD

Celyad

$0.00 (0.00%)Today
    Small Market Cap

    About CYAD

    Celyad Oncology SA engages in the development of cell-based therapies for the treatment of cancer. It operates through the following segments: Cardiology, Immuno-oncology, and Corporate. The Cardiology segment includes the company's Cardiopoiesis, Corquest, and C-Cathez...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Stats

    Market Cap$138,72M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$13.01
    1 Year Low$4.10
    Open$9.75
    High$9.75
    Low$9.75

    Buy any stock with any amount of money.

    Download the App
    Download the app